Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

The Medicines for Europe Board unanimously applauds last night’s vote […]

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Yesterday, 29th November, members of the Competitiveness Council expressed strong […]

Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI)

27 November 2018

The introduction of comprehensive SPC manufacturing waiver key to unlocking […]

Health at a Glance Report highlights public value of generic, biosimilar and value added medicines

26 November 2018

The European Commission and OECD – Health at a Glance: […]

Value added medicines: Continuous innovation crucial to improve healthcare across Europe

21 November 2018

The 2nd Value Added Medicines conference gathered a wide range […]

Driving local excellence, delivering European results

5 November 2018

Medicines for Europe is glad to announce the occasion of […]

US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver

22 October 2018

The US patent and trademark office (USPTO), together with the […]

Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers

11 October 2018

There is a concrete risk that disproportionate influence on the […]

CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court

20 September 2018

An English Court has determined that the contested supplementary protection […]

SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform

17 September 2018

Medicines for Europe welcomes the European Parliament’s Committee on Environment, […]

Newsroom

News about

By type

Twitter

Videos

Photos

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI)

27 November 2018

Health at a Glance Report highlights public value of generic, biosimilar and value added medicines

26 November 2018

Value added medicines: Continuous innovation crucial to improve healthcare across Europe

21 November 2018

Driving local excellence, delivering European results

5 November 2018

US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver

22 October 2018

Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers

11 October 2018

CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court

20 September 2018

SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform

17 September 2018

Subscribe to our newsletter

Share on Mastodon